Q Therapeutics
Latest round
- Series B
Last raised
- Feb 2008
Total raised
- $15M
Investors
- 7
About Q Therapeutics
Q Therapeutics Inc.Q Therapeutics Inc. specializes in creating human-cell-based therapies, with its headquarters located in Salt Lake City, US. Founded by M. Mahendra, the company has undergone significant changes in its business strategy and has successfully advanced its product pipeline.Q Therapeutics focuses on developing innovative human-cell-based therapies aimed at treating currently incurable diseases of the central nervous system (CNS), primarily through its flagship product, Q-Cells®. These human glial progenitor cells are designed to support, repair, and maintain neuronal function in the brain and spinal cord. The technology has shown the ability to replicate, migrate, and differentiate into specialized glial cells at sites of CNS injury or disease.The specific revenue structure of Q Therapeutics is not publicly disclosed. The company operates within a typical biopharmaceutical framework, likely involving transactions with healthcare institutions, hospitals, and clinical research organizations. Revenue generation may stem from sales of Q-Cells® as an off-the-shelf pharmaceutical product, prepared for therapeutic use upon regulatory approval. The company’s focus on CNS diseases suggests revenue will heavily depend on partnerships with healthcare providers for clinical trials and future commercial distribution, contingent upon successful regulatory approvals. The company plans to enhance its offerings and potentially explore new markets, particularly in North America, while considering future expansion into other regions as product development progresses. The focus will include launching new products to address CNS diseases and establishing partnerships with healthcare providers for further clinical trials and distribution opportunities.
Who invested in Q Therapeutics
7 investors across 1 round
See all investors in Q Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Feb 15, 2008
Amount
$15M
Investors
Questions about Q Therapeutics
Who invested in Q Therapeutics?
Q Therapeutics has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Q Therapeutics raised?
Q Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Q Therapeutics last raise money?
Q Therapeutics's most recent round on record is a Series B, in Feb 2008.
What does Q Therapeutics do?
Q Therapeutics is a pharmaceuticals company.
Where is Q Therapeutics headquartered?
Q Therapeutics is headquartered in Salt Lake City, US.
Which VCs invest in companies like Q Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Q Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Q Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.